TP53 and cancer: The deletion of the 17p arm (del17p), where the TP53 gene is located, is a large genetic alteration frequently observed in various human cancers, leading to the loss of not only p53 but also the reduced expression of hundreds of other genes, with the possible adverse risk of haploinsufficiency [92,93].